GlassScriptPhysician profile
Jeffrey C Applewhite
NPI 1437145364
$6,793.38
in general payments reported to CMS, 2019-2025
42 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $818 · 2020: $525 · 2021: $1,502 · 2022: $1,312 · 2023: $877 · 2024: $1,017 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,523 · Grant: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.05 |
| Grant | $113.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,285.43 | 2019-2025 | Xtandi, Myrbetriq |
| Abbvie INC. | $908.76 | 2019-2025 | Lupron Depot, Botox |
| Boston Scientific Corporation | $800.15 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Janssen Biotech, INC. | $571.00 | 2019-2024 | Akeega, Erleada |
| Myovant Sciences INC. | $252.49 | 2021-2022 | |
| Urogen Pharma, INC. | $248.21 | 2022-2025 | Jelmyto |
| Teleflex LLC | $228.21 | 2021-2024 | Urolift |
| Blue Earth Diagnostics | $208.78 | 2019-2025 | Posluma |
| Dendreon Pharmaceuticals LLC | $190.28 | 2021-2023 | Provenge |
| Olympus America INC. | $174.26 | 2024-2025 | Itind System |
| Sumitomo Pharma America, INC. | $167.56 | 2023-2024 | Orgovyx |
| Neotract INC. | $166.12 | 2019-2020 | |
| Axonics, INC. | $142.01 | 2022-2024 | Bulkamid |
| Endo Pharmaceuticals INC. | $138.08 | 2020-2023 | Aveed, Xiaflex |
| Coloplast Corp | $120.55 | 2021-2023 | Speedicath |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $109.49 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Innovation Technologies INC | $109.15 | 2023 | Irrisept |
| Ferring Pharmaceuticals INC. | $98.48 | 2019 | |
| Merck Sharp & Dohme LLC | $92.13 | 2021-2024 | Lynparza, Keytruda, Bridion |
| Genzyme Corporation | $78.37 | 2019 | |
| Urovant Sciences INC | $70.56 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $67.69 | 2023-2024 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $61.87 | 2021-2025 | |
| Cook Medical LLC | $50.12 | 2024-2025 | Resonance |
| Laborie Medical Technologies Corp. | $46.40 | 2022-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Tolmar Pharmaceuticals, INC. | $45.22 | 2021-2022 | |
| Ethicon US, LLC | $41.71 | 2019-2023 | Vistaseal |
| Healthtronics Stone Solutions, LLC | $41.21 | 2022 | |
| Steris Corporation | $37.31 | 2024 | |
| Accord Healthcare, INC. | $33.39 | 2022-2024 | |
| Clarus Therapeutics INC. | $25.95 | 2021 | |
| Travere Therapeutics, INC. | $19.47 | 2021 | |
| Pfizer INC. | $19.41 | 2022 | |
| Ambu INC. | $19.21 | 2023 | |
| Kerecis Limited | $18.88 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Heron Therapeutics, INC. | $18.59 | 2022 | |
| Verity Pharmaceuticals INC. | $16.98 | 2024 | Trelstar |
| Tolmar, INC. | $16.32 | 2025 | Jatenzo, Eligard |
| Baxter Healthcare | $14.75 | 2021 | |
| Medtronic, INC. | $13.70 | 2023 | Interstim |
| Astrazeneca Pharmaceuticals LP | $13.48 | 2023 | Lynparza |
| Mission Pharmacal Company | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Applewhite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.